These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 19838647)

  • 21. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
    J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP; Peng DQ; Yu BL; Huo Y;
    Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Ndrepepa G; King L; Cassese S; Fusaro M; Tada T; Schömig A; Kastrati A
    Eur J Intern Med; 2013 Mar; 24(2):145-50. PubMed ID: 23182629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin use is associated with decreased CD-40 ligand expression on T lymphocytes of coronary atheroma plaque in patients with stable coronary artery disease.
    Türk U; Alioğlu E; Tengiz I; Ercan E; Mahmudov R; Duygu H; Türkoğlu C
    Anadolu Kardiyol Derg; 2008 Apr; 8(2):99-103. PubMed ID: 18400628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total cholesterol content of erythrocyte membranes in acute coronary syndrome: correlation with apolipoprotein A-I and lipoprotein (a).
    Zhang J; Pan L; Xu Y; Wu C; Wang C; Cheng Z; Zhao R
    Coron Artery Dis; 2011 May; 22(3):145-52. PubMed ID: 21317639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging.
    Johnson KM; Dowe DA
    J Am Coll Cardiol; 2014 Sep; 64(9):910-9. PubMed ID: 25169177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective role of statins in patients with acute coronary syndrome aged ≥ 75 years with low LDL-C who underwent percutaneous coronary intervention.
    Bu C; Zhao Y; Ma H; Han H; Yang S; Shi D; Liu Y; Fang Z; Wang Z; Ma Q; Hu B; Yang Q; Li Y; Liu R; Nie B; Zhou Y
    Angiology; 2014 Aug; 65(7):590-5. PubMed ID: 23990595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
    Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
    J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the total cholesterol content of erythrocyte membranes with the severity of disease in stable coronary artery disease.
    Namazi G; Pourfarzam M; Jamshidi Rad S; Movahedian Attar A; Sarrafzadegan N; Sadeghi M; Asa P
    Cholesterol; 2014; 2014():821686. PubMed ID: 25400944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
    Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol end points predict outcome in patients with coronary disease: quality improvement metrics from the enhancing secondary prevention in coronary artery disease (ESP-CAD) trial.
    McAlister FA; Majumdar SR; Lin M; Bakal J; Fradette M; Anderson T
    Can J Cardiol; 2014 Dec; 30(12):1627-32. PubMed ID: 25307535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
    Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of increased temperature of the culprit lesion after recent myocardial infarction: the favorable effect of statins.
    Toutouzas K; Vaina S; Tsiamis E; Vavuranakis M; Mitropoulos J; Bosinakou E; Toutouzas P; Stefanadis C
    Am Heart J; 2004 Nov; 148(5):783-8. PubMed ID: 15523307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical modifications induced by statins therapy on human erythrocytes membranes.
    Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J
    Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Statins in the management of acute coronary syndrome].
    Matoba T; Egashira K
    Nihon Rinsho; 2010 Apr; 68(4):692-8. PubMed ID: 20387563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Shiba M; Wada M; Tsuji T; Komatsu H; Iijima R; Nakajima R; Yamamoto M; Yamamoto M; Yoshitama T; Takagi T; Hara H; Sugi K
    J Cardiol; 2007 Mar; 49(3):115-23. PubMed ID: 17444137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes.
    Gencer B; Auer R; Nanchen D; Räber L; Klingenberg R; Carballo D; Blum M; Vogt P; Carballo S; Meyer P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
    Atherosclerosis; 2015 Mar; 239(1):118-24. PubMed ID: 25585031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study.
    Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Yanagisawa N; Tamura H; Kojima T; Yokoyama K; Kurata T; Daida H
    Atherosclerosis; 2010 Jun; 210(2):497-502. PubMed ID: 20036363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To statin or to non-statin in coronary disease--considering absolute risk is the answer.
    Rembold CM
    Atherosclerosis; 2007 Nov; 195(1):1-6. PubMed ID: 17064710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.